🔗 Visit the ClinicalTrials.gov page for NCT00867178
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 2 | A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes. | Neuro Oncol | 2013 | 0.96 |
| 3 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 4 | Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer. | Cancer Lett | 2012 | 0.86 |
| 5 | Medulloblastoma development: tumor biology informs treatment decisions. | CNS Oncol | 2015 | 0.78 |
| 6 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |
| 7 | The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors. | Curr Treat Options Oncol | 2015 | 0.75 |